BIRELMIS Trademark Information

Trademark by AstraZeneca AB

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: BIRELMIS
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
12/30/2016
Serial Number: 77575737
Filing Date: 9/22/2008
Registration Number: 3791925
Registration Date: 5/25/2010
Goods and Services: Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 7/28/2009
Last Applicant/Owner:
AstraZeneca AB
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
12/30/2016
Correspondent Search:
WM. CHARLES SAUNDERS is a correspondent of BIRELMIS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on